# FDA Inspection 1180929 - Akan Biosciences Inc - September 30, 2022

Source: https://www.keypedia.com/records/fda_inspections/akan-biosciences-inc/7bd9b1e7-bccf-4236-8d2a-a713c2965e93
Source feed: FDA_Inspections

> FDA Inspection 1180929 for Akan Biosciences Inc on September 30, 2022. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1180929
- Company Name: Akan Biosciences Inc
- Inspection Date: 2022-09-30
- Classification: Official Action Indicated (OAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1180929 - 2022-09-30](https://www.keypedia.com/records/fda_inspections/akan-biosciences-inc/c27b3df1-88fa-4af3-b455-422e3f537b76)
- [FDA Inspection 1180929 - 2022-09-30](https://www.keypedia.com/records/fda_inspections/akan-biosciences-inc/94c03acf-3d7c-463b-8559-0e1e25d3916f)

Company: https://www.keypedia.com/companies/akan-biosciences-inc/a48ad3fc-2cb1-4272-95fa-8a816ba7f3d1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d